Thursday, 20 Feb 2020

You are here

RABBIT Risk Scores are Higher in ICU-Admitted RA Patients

The German Rheumatoid Arthritis Biologics Registry (RABBIT) has developed an infectious risk calculator that can project a patient's risk of serious infection in the next 6 months based on several key factors - age, Prior DMARDs, prednisone dose, comorbidities and the biologic intended for use.  (This can be found at http://www.biologika-register.de

Others have used this formula to study whether RA patients admitted to an intensive care unit (ICU) for infection would have higher RABBIT risk scores compared to control RA patients.  They identified 74 RA patients with an infectious ICU admission and compared these to 74 frequency-matched control RA patients.

RABBIT risk scores were significantly higher in ICU RA patients (median 2.0; IQR 1.3-3.2) as compared to controls (1.3; IQR 0.8-2.0; p < 0.0001).  RA patients admitted to the ICU for infection were also more likely to be on DMARDs (82.4 vs 64.9%; p = 0.015), biologics (28.4 vs 14.9%; p = 0.012) and steroids (51.4 vs 31.1%; p = 0.012); suggesting those patients also had more active RA.

In a multivariable analysis conventional DMARD use was associated with lower (OR 0.38) and glucocorticoids with borderline higher odds of ICU admission (OR 2.05).

Chronic obstructive pulmonary disease (OR 2.89), chronic kidney disease (OR 16.08), and age (OR 2.67) were alson strongly associated with ICU admission.

Increasing RABBIT risk scores was associated with a strong trend towards higher odds of ICU admission for infection.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Seronegativity on the Rise in RA

Although the overall incidence rates of rheumatoid arthritis (RA) have remained stable over recent decades, there has been a significant increase in seronegative cases, a retrospective study showed.

Alcohols Net Zero Effect in Rheumatoid Arthritis

A report from The National Databank for Rheumatic Disease addressed the impact of alcohol on disease activity and mortality in rheumatoid arthritis (RA) and found that alcohol use was not associated with changes in disease activity or mortality, after addressing confounders. 

DMARD Inertia by Registry Rheumatologists

A registry study of metric use (primarily RAPID3 and CDAI) in the treatment of rheumatoid arthritis (RA) patients shows that, even in the face of moderate or high disease activity, treatment changes by rheumatologists were relatively low (35.6–54.6%).

Bariatric Weight Loss Fails to Alter RA Risk

Obesity has been shown to be a risk factor for the onset of rheumatoid arthritis (RA) and also shown to affect outcomes by impairing responses to many DMARD therapies. A Swiss study of RA patients undergoing bariatric surgery failed to show that bariatric surgery and weight loss had any effect on the incidence of RA.

Limited Advantage to Very Early vs. Delayed Etanercept in RA

The VEDERA study sought to confirm whether the very early introduction of first-line etanercept+methotrexate (ETN+MTX) was superior to treat-to-target MTX (MTX-TT) in patients with early RA.